370 related articles for article (PubMed ID: 17967773)
1. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.
Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L
Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773
[TBL] [Abstract][Full Text] [Related]
2. A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.
Hovingh GK; Brownlie A; Bisoendial RJ; Dube MP; Levels JH; Petersen W; Dullaart RP; Stroes ES; Zwinderman AH; de Groot E; Hayden MR; Kuivenhoven JA; Kastelein JJ
J Am Coll Cardiol; 2004 Oct; 44(7):1429-35. PubMed ID: 15464323
[TBL] [Abstract][Full Text] [Related]
3. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis.
John S; Jacobi J; Delles C; Schlaich MP; Alter O; Schmieder RE
Clin Sci (Lond); 2000 May; 98(5):521-9. PubMed ID: 10781382
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major.
Aggeli C; Antoniades C; Cosma C; Chrysohoou C; Tousoulis D; Ladis V; Karageorga M; Pitsavos C; Stefanadis C
Int J Cardiol; 2005 Oct; 105(1):80-4. PubMed ID: 16207549
[TBL] [Abstract][Full Text] [Related]
5. Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells.
Higashi Y; Matsuoka H; Umei H; Sugano R; Fujii Y; Soga J; Kihara Y; Chayama K; Imaizumi T
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E202-9. PubMed ID: 19903864
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins.
Calabresi L; Franceschini G; Sirtori CR; De Palma A; Saresella M; Ferrante P; Taramelli D
Biochem Biophys Res Commun; 1997 Sep; 238(1):61-5. PubMed ID: 9299452
[TBL] [Abstract][Full Text] [Related]
7. Effects of lipoproteins from pre-eclamptic women on umbilical endothelial cell 6-oxo-prostaglandin f1alpha and endothelin 1 synthesis, and nitric oxide synthase 3 mRNA expression.
Barden A; Beilin LJ; Both K; Ritchie J; Leedman P; Walters BN; Michael CA
Clin Sci (Lond); 1999 Dec; 97(6):697-706. PubMed ID: 10585897
[TBL] [Abstract][Full Text] [Related]
8. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy.
Sorrentino SA; Besler C; Rohrer L; Meyer M; Heinrich K; Bahlmann FH; Mueller M; Horváth T; Doerries C; Heinemann M; Flemmer S; Markowski A; Manes C; Bahr MJ; Haller H; von Eckardstein A; Drexler H; Landmesser U
Circulation; 2010 Jan; 121(1):110-22. PubMed ID: 20026785
[TBL] [Abstract][Full Text] [Related]
9. Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function.
Balstad TR; Holven KB; Ottestad IO; Otterdal K; Halvorsen B; Myhre AM; Ose L; Nenseter MS
Clin Chim Acta; 2005 Sep; 359(1-2):171-8. PubMed ID: 15936009
[TBL] [Abstract][Full Text] [Related]
10. High-density lipoprotein apolipoprotein A-I kinetics in obesity.
Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
Obes Res; 2005 Jun; 13(6):1008-16. PubMed ID: 15976143
[TBL] [Abstract][Full Text] [Related]
11. Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms.
Jia L; Bai H; Fu M; Xu Y; Yang Y; Long S
Clin Chim Acta; 2005 Oct; 360(1-2):37-45. PubMed ID: 15925353
[TBL] [Abstract][Full Text] [Related]
12. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein.
Bisoendial RJ; Hovingh GK; Levels JH; Lerch PG; Andresen I; Hayden MR; Kastelein JJ; Stroes ES
Circulation; 2003 Jun; 107(23):2944-8. PubMed ID: 12771001
[TBL] [Abstract][Full Text] [Related]
13. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of apolipoprotein A I, A II, C I and C II on endothelial cells injury induced by low density lipoprotein.
Li J; Jiang L; Liu Q
Chin Med J (Engl); 1998 Jan; 111(1):78-81. PubMed ID: 10322661
[TBL] [Abstract][Full Text] [Related]
15. Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training.
Ostergård T; Nyholm B; Hansen TK; Rasmussen LM; Ingerslev J; Sørensen KE; Bøtker HE; Saltin B; Schmitz O
Metabolism; 2006 Nov; 55(11):1508-15. PubMed ID: 17046554
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study.
Sirtori CR; Calabresi L; Franceschini G; Baldassarre D; Amato M; Johansson J; Salvetti M; Monteduro C; Zulli R; Muiesan ML; Agabiti-Rosei E
Circulation; 2001 Apr; 103(15):1949-54. PubMed ID: 11306522
[TBL] [Abstract][Full Text] [Related]
17. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects.
Oshima T; Ozono R; Yano Y; Oishi Y; Teragawa H; Higashi Y; Yoshizumi M; Kambe M
J Am Coll Cardiol; 2005 Apr; 45(8):1219-22. PubMed ID: 15837252
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
Eur J Clin Invest; 2006 Sep; 36(9):626-32. PubMed ID: 16919045
[TBL] [Abstract][Full Text] [Related]
19. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin is an important determinant of apoA-I catabolism.
Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
